Early screening for respiratory and cardiac complications in pediatric mucopolysaccharidosis IVA: Insights from a case. [PDF]
Shu H +5 more
europepmc +1 more source
Identification of Multiple Sulfatase Deficiency (MSD) in newborn screening: A case study. [PDF]
Donti TR +4 more
europepmc +1 more source
Three-dimensional human mucopolysaccharidosis IVA chondrocyte culture reveals significant impairments in the lysosomal-mitochondrial crosstalk. [PDF]
Leal AF, Saikia S, Khan SA, Tomatsu S.
europepmc +1 more source
Mucopolysaccharidosis type IVA (MPS IVA) is caused by a deficiency of the galactosamine (N-acetyl)-6-sulfatase (GALNS) enzyme responsible for the degradation of specific glycosaminoglycans (GAGs).
Fnu, Nidhi +6 more
core
CRISPR/nCas9-Edited CD34+ Cells Rescue Mucopolysaccharidosis IVA Fibroblasts Phenotype. [PDF]
Herreno-Pachón AM +4 more
europepmc +1 more source
A Rare Case of Morquio Syndrome in Palestine: Clinical, Radiological, and Genetic Insights. [PDF]
Farah RE +3 more
europepmc +1 more source
A Novel Missense Mutation of c.965C>T (p.Ala322Val) in the Human <i>GALNS</i> Gene Results in Severe Mucopolysaccharidosis Type IVA. [PDF]
Safavi M, Setoodeh A, Ghoddoosi M.
europepmc +1 more source
Rat models of musculoskeletal lysosomal storage disorders and their role in pre-clinical evaluation of gene therapy approaches. [PDF]
Marcó S, Muñoz S, Bosch F, Jimenez V.
europepmc +1 more source
Lentiviral Vector-Mediated <i>Ex Vivo</i> Hematopoietic Stem Cell Gene Therapy for Mucopolysaccharidosis IVA Murine Model. [PDF]
Celik B +5 more
europepmc +1 more source
Mucopolysaccharidosis type IVA and severe hidradenitis suppurativa: A case series. [PDF]
Fialová J +3 more
europepmc +1 more source

